Fritextsökning
Innehållstyper
-
Studie: Ovanligare med återinfektion i covid hos barn än hos vuxna
Återinfektioner i covid-19 förekom mer under deltavågen än under alfavågen och barn återinfekterades i lägre utsträckning än vuxna, enligt en ny studie.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Nu sänds första avsnittet av Life Science-podden
Temat i avsnittet är coronavirus och covid-19.
-
Studie beskriver hur coronavirus trivs på olika ytor
En ny studie från KTH ökar förståelsen av hur sars-cov-2 interagerar med olika ytor på molekylär nivå.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
Negativa resultat i ny covidstudie med malariamedel
Ett malariamedel som prövas mot covid-19 gav inte effekt, enligt de första resultaten från en stor placebokontrollerad studie. Samtidigt hissar tidskriften Lanc...
-
Ola Weiland: ”Det är sällan man lyckas med en sån bedrift”
”Alla tre var viktiga och jag tycker det var rätt beslut”, säger Ola Weiland, senior professor i infektionssjukdomar vid Karolinska institutet, om valet av pris...
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Measure blood sugar without finger pricking
The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a sma...
-
Nexium-mål läggs ned
Domstol i Boston lägger ner konkurrensmål där Astrazeneca anklagas för att ha fördröjt generikalanseringar
-
Per Norstedt, Regional Manager, AH Diagnostics
Why are you going to Scanlab+Biotech Forum?
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
Platelet analysis in whole blood
The new Multiplate analyzer from Triolab uses impedance aggregometry to measure the effects of platelet inhibitors on whole blood.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Double the channels for half the work
The 16-well pipettes from Capp cause less strain for the user when setting up a 384-well plate.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Konsolidering i medtech-branschen
Nya hälsovårdsprogrammet Medicare sätter press på utbuden hos medicinteknikbolagen i USA. Nu planerar två jättar att slå sina påsar ihop.
BREAKING